My first guess is that they are measuring the circulating cancer cells in our cancer trials.

I think we've said there are a dozen leronlimab-treated women with mTNBC that have zero CTCs in their blood. CreatV BioTech appears to be the best at that measurement. I might hope they will say how rare it is to see a drug achieve that.